There is still time to RSVP. Please visit www.safeguard.com/InvestorDay2014 by Monday, October 13th to RSVP and submit your one-on-one requests.
Wayne, PA (PRWEB) October 09, 2014
Safeguard Scientifics, Inc. (NYSE:SFE) will be hosting its 8th Annual Investor Day at the New York Stock Exchange on Wednesday, October 15, 2014 from 8:00am–12:15pm EDT. Investor Day 2014 will offer the investor community an opportunity to hear from Safeguard’s executive team along with executives from Safeguard’s partner companies about growth opportunities and value creation strategies.
Registration and Breakfast
- John E. Shave III – SVP, Investor Relations and Corporate Communications, Safeguard Scientifics
- Stephen T. Zarrilli – President and CEO, Safeguard Scientifics
- Jeffrey B. McGroarty – SVP and CFO, Safeguard Scientifics
Good Start Genetics
- Don Hardison, CEO, Good Start Genetics
- Ben Kartzman, Co-Founder and CEO, Spongecell
- Rakesh Malhotra, VP of Products, Apprenda
- Jean Hoffman, Founder, President and CEO, Putney
- Sundeep Bhan, Co-Founder and CEO, Medivo
- Joe Zawadski, Co-Founder and CEO, MediaMath
Closing Remarks followed by Luncheon with Informal Conversation
Please note that presenting partner companies and agenda are subject to change.
Please call / login at least 15 minutes prior to register.
Call-in Number: 877-201-0168
Replay Number: 855-859-2056
Replay Access Code: 81291746
Replay available through January 15, 2015 at 11:59am EST.
RSVP and One-on-ones:
There is still time to RSVP. Please visit http://www.safeguard.com/InvestorDay2014 by Monday, October 13th to RSVP and submit your one-on-one requests.
*Please note that due to security restrictions at the New York Stock Exchange, pre-registration is required.
The following Safeguard executives will be available for one-on-one meetings to discuss Safeguard’s portfolio of healthcare and technology companies, in its entirety, along with industry trends and growth opportunities:
- Stephen T. Zarrilli – President and CEO
- Brian J. Sisko – EVP, COO and Managing Director
- Jeffrey B. McGroarty – SVP and CFOGary J. Kurtzman, MD – SVP and Managing Director, Healthcare
- Philip D. Moyer – SVP and Managing Director, Technology
- Erik B. Rasmussen – SVP and Managing Director, Technology
- Al Wiegman – VP and Managing Director, Healthcare
The following partner company executives will be available for one-on-one meetings (alpha order by company name):
- Apprenda – Rakesh Malhotra, VP of Products
- Good Start Genetics – Don Hardison, CEO
- MediaMath – Joe Zawadski, Co-Founder and CEO
- Medivo – Sundeep Bhan, Co-Founder and CEO
- Spongecell – Ben Kartzman, Co-Founder and CEO
Please contact us at (610) 975-4944 or IR(at)safeguard(dot)com.
About Safeguard Scientifics
Safeguard Scientifics, Inc. (NYSE:SFE) has a distinguished track record of fostering innovation and building market leaders. For six decades, Safeguard has been providing growth capital and operational support to entrepreneurs across an evolving spectrum of industries. Today, Safeguard is focused specifically on two sectors—healthcare and technology. Recent successful exits include Alverix (acquired by Becton, Dickinson for $40 million); Crescendo Bioscience (acquired by Myriad Genetics for $270 million); NuPathe (acquired by Teva Pharmaceutical Industries for $144 million); and ThingWorx (acquired by PTC for initial proceeds of $112 million). For more information, please visit http://www.safeguard.com or Follow Us on Twitter @safeguard.
Except for the historical information and discussions contained herein, statements contained in this release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements are subject to risks and uncertainties. The risks and uncertainties that could cause actual results to differ materially include, among others, our ability to make good decisions about the deployment of capital, the fact that our partner companies may vary from period to period, our substantial capital requirements and absence of liquidity from our partner company holdings, fluctuations in the market prices of our publicly traded partner company holdings, competition, our inability to obtain maximum value for our partner company holdings, our ability to attract and retain qualified employees, market valuations in sectors in which our partner companies operate, our inability to control our partner companies, our need to manage our assets to avoid registration under the Investment Company Act of 1940, and risks associated with our partner companies, including the fact that most of our partner companies have a limited history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which Safeguard’s partner companies operate, and other uncertainties described in our filings with the Securities and Exchange Commission. Many of these factors are beyond the Company’s ability to predict or control. As a result of these and other factors, the Company’s past financial performance should not be relied on as an indication of future performance. The Company does not assume any obligation to update any forward-looking statements or other information contained in this press release.